| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 12, 2005
Accepted on December 27, 2005
Endocrine-metabolic laboratory, Dept. of Medical and Surgical Sciences, University of Padua, Italy, Liver Unit, Internal Medicine, Dept. of Pathology and Experimental and Clinical Medicine, University of Udine, Italy, Pathology Unit, University of Udine, Italy, Dept of Laboratory Medicine, University-Hospital of Padua, Italy
* To whom correspondence should be addressed. E-mail: claudio.pagano{at}unipd.it.
Context: The recently discovered hormone resitin is linked to the development of insulin resistance but direct evidence of resistin levels in humans with nonalcoholic fatty liver disease (NAFLD) is lacking.
Methods: We conducted this study to assess the relationship between serum resistin and NAFLD. We measured serum resistin, biochemical, hormonal and histological correlates in 28 NAFLD patients, 33 controls and 30 obese patients (BMI>30 kg/m2) without NAFLD.
Results: Resistin and adiponectin expression were measured in sc adipose tissue by qRT-PCR. Resistin was higher in NAFLD patients compared with control (5.87 ± 0.49 vs. 4.30 ± 0.20 ng/mL, P = 0.002) and obese patients (4.37 ± 0.27 ng/ml, P = 0.002). Increased resistin mRNA was found also in adipose tissue of NAFLD patients compared with controls and obese subjects.
Conclusions: Both NAFLD and obese patients had lower adiponectin while leptin was elevated only in the obese group. No correlation was found between resistin and hs-CRP, BMI, HOMA, insulin, glucose, transaminases and lipid values. A positive correlation was found between resistin and histological inflammatory score. These data report increased resistin in NAFLD patients which is related to histological severity of the disease, while do not support a link between resistin and insulin resistance or BMI in these patients.
This article has been cited by other articles:
![]() |
N. Anderson and J. Borlak Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Singhal, R. T. Patel, Y. Qi, Y.-S. Lee, and R. S. Ahima Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E331 - E338. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Forsblad d'Elia, R. Pullerits, H. Carlsten, and M. Bokarewa Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis Rheumatology, July 1, 2008; 47(7): 1082 - 1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saito, N. Yamaguchi, Y. Shimazaki, H. Hayashida, K. Yonemoto, Y. Doi, Y. Kiyohara, M. Iida, and Y. Yamashita Serum Levels of Resistin and Adiponectin in Women with Periodontitis: the Hisayama Study J. Dent. Res., April 1, 2008; 87(4): 319 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bertola, S. Bonnafous, M. Cormont, R. Anty, J.-F. Tanti, A. Tran, Y. Le Marchand-Brustel, and P. Gual Hepatocyte Growth Factor Induces Glucose Uptake in 3T3-L1 Adipocytes through A Gab1/Phosphatidylinositol 3-Kinase/Glut4 Pathway J. Biol. Chem., April 6, 2007; 282(14): 10325 - 10332. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Silha, B.L. G. Nyomba, W. D. Leslie, and L. J. Murphy Ethnicity, Insulin Resistance, and Inflammatory Adipokines in Women at High and Low Risk for Vascular Disease Diabetes Care, February 1, 2007; 30(2): 286 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Perseghin, G. Lattuada, F. De Cobelli, G. Ntali, A. Esposito, A. Burska, E. Belloni, T. Canu, F. Ragogna, P. Scifo, et al. Serum Resistin and Hepatic Fat Content in Nondiabetic Individuals J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5122 - 5125. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bertolani, P. Sancho-Bru, P. Failli, R. Bataller, S. Aleffi, R. DeFranco, B. Mazzinghi, P. Romagnani, S. Milani, P. Gines, et al. Resistin as an Intrahepatic Cytokine: Overexpression during Chronic Injury and Induction of Proinflammatory Actions in Hepatic Stellate Cells Am. J. Pathol., December 1, 2006; 169(6): 2042 - 2053. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |